Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 19:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- DKK 34.48T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | DKK 32.3B | DKK 92.01 | 2.81% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | DKK 65.1B | DKK 685.41 | 7.20% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | DKK 44.2B | DKK 651.70 | 0.73% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | DKK 35.9B | DKK 850.25 | 0.71% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | DKK 26.8B | DKK 195.45 | 2.40% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | DKK 50.8B | DKK 647.10 | 0.18% down | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | DKK 32.7B | DKK 580.51 | 2.08% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | DKK 67.6B | DKK 447.12 | 4.61% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | DKK 161B | DKK 140.44 | 0.76% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | DKK 190.2B | DKK 262.45 | 0.53% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | DKK 30.9B | DKK 281.97 | 1.59% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | DKK 51.8B | DKK 148.62 | 3.24% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | DKK 271.6B | DKK 472.41 | 0.92% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | DKK 335.1B | DKK 287.22 | 1.13% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | DKK 215.4B | DKK 349.28 | 1.38% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | DKK 58.4B | DKK 2,088.88 | 0.46% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | DKK 53.1B | DKK 316.12 | 2.05% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | DKK 463.5B | DKK 145.08 | 1.64% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | DKK 2.31T | DKK 936.34 | 4.18% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | DKK 56B | DKK 858.67 | 1.05% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | DKK 33B | DKK 343.97 | 1.24% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | DKK 40.7B | DKK 2,035.64 | 1.65% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | DKK 4.48T | DKK 1,863.00 | 1.93% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | DKK 107.9B | DKK 1,681.56 | 2.49% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | DKK 667.8B | DKK 6,455.83 | 1.11% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | DKK 8.39T | DKK 9,415.27 | 2.41% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | DKK 831.9B | DKK 406.98 | 2.67% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | DKK 43B | DKK 1,058.75 | 1.51% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | DKK 41.2B | DKK 630.57 | 0.61% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | DKK 121B | DKK 1,844.59 | 0.21% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | DKK 928.3B | DKK 3,661.24 | 0.55% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | DKK 3.44T | DKK 1,945.35 | 2.53% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | DKK 2T | DKK 1,056.33 | 2.61% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | DKK 168B | DKK 3,945.70 | 0.89% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | DKK 91.5B | DKK 183.04 | 3.89% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | DKK 103.4B | DKK 530.62 | 1.37% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | DKK 314.2B | DKK 2,750.91 | 2.34% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | DKK 1.09T | DKK 191.36 | 1.39% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | DKK 56.3B | DKK 811.84 | 2.14% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | DKK 81.1B | DKK 418.53 | 4.95% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | DKK 41.8B | DKK 295.44 | 0.83% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | DKK 664.8B | DKK 331.66 | 1.18% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | DKK 85.2B | DKK 102.18 | 1.36% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | DKK 1.89T | DKK 1,216.78 | 2.06% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | DKK 39B | DKK 57.36 | 2.49% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | DKK 772.8B | DKK 321.85 | 0.65% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | DKK 48.1B | DKK 913.88 | 1.38% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | DKK 50.6B | DKK 462.77 | 3.10% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | DKK 1.18T | DKK 268.82 | 3.10% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | DKK 1.23T | DKK 712.64 | 0.15% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | DKK 34.2B | DKK 409.64 | 0.43% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | DKK 48.7B | DKK 349.66 | 0.68% down | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | DKK 33.1B | DKK 190.47 | 0.34% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | DKK 63.7B | DKK 2,740.68 | 4.71% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | DKK 49.9B | DKK 569.98 | 1.86% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | DKK 237.6B | DKK 584.81 | 2.78% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | DKK 57.2B | DKK 71.46 | 1.73% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | DKK 179.5B | DKK 818.18 | 1.49% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | DKK 21.4B | DKK 110.28 | 0.43% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | DKK 31.6B | DKK 189.52 | 3.13% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | DKK 135.5B | DKK 1,011.55 | 5.17% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8159 DKK).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 19:53 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of DKK 34.48T as of 18 Nov 2026, 19:53 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.